7NVH
Cryo-EM structure of the mycolic acid transporter MmpL3 from M. tuberculosis
7NVH の概要
エントリーDOI | 10.2210/pdb7nvh/pdb |
EMDBエントリー | 12604 |
分子名称 | Trehalose monomycolate exporter MmpL3, Lauryl Maltose Neopentyl Glycol (2 entities in total) |
機能のキーワード | transporter, membrane protein |
由来する生物種 | Mycobacterium tuberculosis |
タンパク質・核酸の鎖数 | 1 |
化学式量合計 | 83530.80 |
構造登録者 | Adams, O.,Deme, J.C.,Parker, J.L.,Lea, S.M.,Newstead, S. (登録日: 2021-03-15, 公開日: 2021-06-16, 最終更新日: 2025-07-09) |
主引用文献 | Adams, O.,Deme, J.C.,Parker, J.L.,Fowler, P.W.,Lea, S.M.,Newstead, S. Cryo-EM structure and resistance landscape of M. tuberculosis MmpL3: An emergent therapeutic target. Structure, 29:1182-1191.e4, 2021 Cited by PubMed Abstract: Tuberculosis (TB) is the leading cause of death from a single infectious agent and in 2019 an estimated 10 million people worldwide contracted the disease. Although treatments for TB exist, continual emergence of drug-resistant variants necessitates urgent development of novel antituberculars. An important new target is the lipid transporter MmpL3, which is required for construction of the unique cell envelope that shields Mycobacterium tuberculosis (Mtb) from the immune system. However, a structural understanding of the mutations in Mtb MmpL3 that confer resistance to the many preclinical leads is lacking, hampering efforts to circumvent resistance mechanisms. Here, we present the cryoelectron microscopy structure of Mtb MmpL3 and use it to comprehensively analyze the mutational landscape of drug resistance. Our data provide a rational explanation for resistance variants local to the central drug binding site, and also highlight a potential alternative route to resistance operating within the periplasmic domain. PubMed: 34242558DOI: 10.1016/j.str.2021.06.013 主引用文献が同じPDBエントリー |
実験手法 | ELECTRON MICROSCOPY (3 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード
